Is tissue tumour mutational burden a predictive biomarker for immunotherapy in lung cancer?
Two post-hoc analyses of KEYNOTE studies presented at ESMO 2019
Precision medicine bursts onto the biliary tract cancer scene
The management of biliary tract cancers, especially cholangiocarcinoma, is rapidly changing with emerging new precision medicine strategies
From research bench to the patient’s bedside
ESMO Congress 2019 held in Barcelona, Spain, from 27 September to 1 October 2019
Adding FOLFIRINOX to nab-PG may improve outcomes in pancreatic cancer
Results from the phase II NEOLAP study presented at ESMO 2019